Investigator Site #1

Lawrenceville, Georgia 30046

2 studies enrolling now · 2 studies all time

What they study most

C3 (Complement Component 3) Glomerulopathy, Focal Segmental Glomerulosclerosis, IgA Nephropathy, Lupus Nephritis (LN)

Studies at this site

• A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G — Recruiting now
• A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS) — Recruiting now